Brind.

Allegations of a price-fixing scheme regarding insulin costs involving Princeton University, Eli Lilly, Sanofi-Aventis, and Novo Nordisk.

1 report, 1 independent Updated Sep 10

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Princeton University Eli Lilly and Company Sanofi-Aventis Novo Nordisk

Keep exploring

The entities involved

Princeton University
private Ivy League research university in Princeton, New Jersey, United States
- A ranking review reveals that institutions including UChicago, Princeton, and MIT are facing a major shift, having lost the top spot and settling in second place.Mon 14:22
- Trump administration canceled climate research grants at Princeton University.Mon 13:50
Eli Lilly and Company
American pharmaceutical company
- ExxonMobil, Berkshire Hathaway, and Eli Lilly are top holdings in the Avantis ETF.Mon 17:18
- The FDA approved Olumiant for pediatric indications on September 1, 2026.Mon 05:59
Sanofi-Aventis
US company, subsidiary of Sanofi

Nothing else this week.
Novo Nordisk
Danish pharmaceutical company
- BridgeBio and Novo Nordisk have both made filings under the KXCO Ontology.Mon 10:09
- CMS introduced the Medicare drug price negotiation program, and companies are facing challenges regarding pricing and market access.Mon 00:08

Related events

Coverage

Newest first; wire copies grouped

Sep 10dailyprincetonian.com